Itoh M, Streuli M, Krueger N X, Saito H
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
J Biol Chem. 1992 Jun 15;267(17):12356-63.
Human HPTP beta, leukocyte common antigen (LCA), and leukocyte common antigen-related molecule (LAR) are transmembrane receptor-like proteins whose cytoplasmic regions contain either one (HPTP beta) or two (LCA and LAR) domains that are homologous to protein tyrosine phosphatases (PTPases). Whereas the membrane-proximal domain 1 has enzymatic activity, the membrane-distal domain 2 of both LCA and LAR has no detectable catalytic activity. The cytoplasmic regions of HPTP beta, LCA, and LAR were expressed in Escherichia coli and purified to greater than 90% purity. Modulatory effects of various low molecular weight compounds and homo- and copolymers of amino acids were examined. Several polypeptides that contain a high proportion of tyrosine were strongly inhibitory to these PTPases. To determine a possible role for the LAR domain 2, the properties of recombinant LAR PTPases containing both domains 1 and 2 (LAR-D1D2) or only domain 1 (LAR-D1) were compared. In nearly all aspects examined, LAR-D1 and LAR-D1D2 were indistinguishable. However, polycationic polypeptides strongly stimulated the PTPase activity of LAR-D1D2, but not LAR-D1, using the peptide substrate Raytide. Thus, basic polypeptides seem to indirectly alter the catalytic activity of domain 1 by interacting with domain 2. This result suggests that domain 2 has a regulatory function.
人HPTPβ、白细胞共同抗原(LCA)和白细胞共同抗原相关分子(LAR)是跨膜受体样蛋白,其胞质区域含有一个(HPTPβ)或两个(LCA和LAR)与蛋白酪氨酸磷酸酶(PTPases)同源的结构域。虽然膜近端结构域1具有酶活性,但LCA和LAR的膜远端结构域2均无可检测的催化活性。HPTPβ、LCA和LAR的胞质区域在大肠杆菌中表达并纯化至纯度大于90%。研究了各种低分子量化合物以及氨基酸的同聚物和共聚物的调节作用。几种酪氨酸比例高的多肽对这些PTPases具有强烈的抑制作用。为了确定LAR结构域2的可能作用,比较了包含结构域1和2(LAR-D1D2)或仅包含结构域1(LAR-D1)的重组LAR PTPases的特性。在几乎所有检测的方面,LAR-D1和LAR-D1D2没有区别。然而,使用肽底物Raytide时,聚阳离子多肽强烈刺激LAR-D1D2的PTPase活性,但不刺激LAR-D1。因此,碱性多肽似乎通过与结构域2相互作用间接改变结构域1的催化活性。这一结果表明结构域2具有调节功能。